NASP is pleased to present the publication of 67 peer-reviewed abstracts that were presented at the NASP 2022 Annual Meeting & Expo. NASP extends its heartfelt appreciation to the authors who participated in the poster display of their work and were on hand to answer attendee questions and further expound on their research and results.

Publication

View all 2022 published abstracts in the Taylor & Francis MEDLINE-indexed journal Current Medical Research & Opinion (CMRO).

Categories of abstracts submissions included:

  • Delivery of Specialty Pharmacy Products or Services
  • Adherence
  • Outcomes (Cost or Other)
  • COVID-19 Products or Services

Abstracts accepted for presentation at the NASP Annual Meeting & Expo must reflect completed research and are based on the following: novelty of the research, significance of the findings, relevance to specialty pharmacy, and clarity. Submission of previously presented research is permitted.

2022 Poster Winners

With NASP members serving as poster judges, award winners were announced on Thursday, September 22 in the following categories:

To view abstract posters, please click on the abstract titles below.

CE home study credit is available in the Education Center for 2022 Annual Meeting & Expo posters. Click here to access the Education Center.

Follow the Script: Assessing Access Time and Adherence in Patients with MS

Authors: Hickman A, PharmD, MPH, MSCS; Skrtic A, PharmD; Webster N, PharmD candidate 2022; Canup K, PharmD; D’Angelo N, PharmD, MSCS; Roselli M, PharmD; Tiger K, PharmD; Wang H, PharmD, MSCS; Zitterkopf C; PharmD; Kimball S, PharmD Candidate; Kow J, PharmD Candidate; Patel H, PharmD; Tran P, PharmD Candidate; Waite S, PharmD

Impact of an adherence texting program in a large national specialty pharmacy

Authors: Helen Kim, PharmD, BCGP; Stephanie LaPointe, PharmD; Kelly Mathews, PharmD, CSP; Clarisse Purvis, PhD

Comparison of Discontinuation Rates in Patients Receiving an Oral Anticancer Agent Before and After Implementation of a 14-day Pharmacist Check-in Protocol

Authors: Kristin Hutchinson, PharmD, BCOP, CSP; Jasmine King, PharmD Candidate; Jessica Mourani, PharmD; Angie Wood, PharmD, BCPS, BCOP, CSP; Mike Latran, PharmD, MPH

RISKS OF LOW ADHERENCE IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS

Authors: Allison Nguyen, PharmD; Jennifer Yen, PharmD, BCPPS, Lois Sayrs, PhD; Katie Tu, PharmD

HealthBeacon: Smart Reminders Improve Adherence

Authors: Sharifah Sarhan, MB BCH BAO; Rohit Chougule, MSc; Nilesh Aher, MSc; Sean McWhinney, PhD

Machine Learning for Adverse Events: PREDICT

Authors: Kali Sassack, PharmD, BCPS, CSP; Lori Grebe, RPh, CSP; Elizabeth McDade, PharmD, BCOP; Cali Runtas, MS

Impact of a Nurse-Led Compliance and Persistence Program on Patient Compliance with Oral Oncology Therapies

Authors: Dipti Shah, PharmD, CSP; Kelly McAuliff, PharmD, BCOP, CSP; Pavlo Kyrychenko, MD, PhD; Elisea AvalosReyes, PhD; W. Cliff Rutter, PharmD, PhD; Rashmi Grover, PharmD; Lucia Feczko, RPh; Kjel Johnson, PharmD

Patient-Tailored Pharmacist Interventions to Improve Specialty Medication Adherence: A Randomized Controlled Trial

Authors: Amanda M. Kibbons; Ryan Moore; Leena Choi; Autumn D. Zuckerman

COVID-19 Impact on Multiple Myeloma Prescribing Patterns

Authors: Dipti Shah, PharmD, CSP; Kelly McAuliff, PharmD, BCOP, CSP; Amanda McCarthy, MPH; Will Cavers, MSc; Rashmi Grover, PharmD; Lucia Feczko, RPh; Elias Pittos, PharmD, BCOP, CSP; Elisea Avalos-Reyes, PhD; Kjel Johnson, PharmD

Impact of COVID-19 on Oral Oncolytic Adherence

Authors: Kelly McAuliff, PharmD, BCOP, CSP; W. Cliff Rutter, PharmD, PhD; Will Cavers, MSc; Dipti Shah, PharmD, CSP; Elias Pittos, PharmD, BCOP, CSP; Lucia Feczko, RPh; Rashmi Grover, PharmD; Elisea Avalos-Reyes, PhD; Kjel Johnson, PharmD

Technician Enhancement Within Specialty Pharmacy

Authors: Alijah Kosarko, BA, CPhT; Vanessa Batista, CPhT; Terri Sue Rubino, Pharm D, CSP; Vinay Sawant, RPh, MPH, MBA

How Specialty Pharmacy Enhances The Patient Experience

Author: Douglas Braun, PharmD, RPh, CSP, CPh

Biosimilar Benefit Use, Adoption, and Conversions

Authors: Richard A. Brook, MS, MBA; Alek A. Drnach, MS; Ian A. Beren, BS; Nathan L. Kleinman, PhD; Eric M. Rosenberg, MA

Moving towards meaningful patient outcomes in rare disease: Achondroplasia case study

Author: Jay Bryant-Wimp, RPh

Leveraging Technology for Specialty Refills

Authors: Danielle Burkhart, PharmD, MBA, BCACP; Richard Demers, MS, RPh, FASHP; Mohan Balachandran, MA, MS; Christianne Sevinc, MPH; Beth Dewan, RPh; Richard Fiore, RPh; Natalie Goode, PharmD, BCACP; Jaclyn Barone, PharmD; Troy Rehrig, PharmD, MS; Daniel Rubin, PharmD, BCOP; Joseph Favatella, PharmD, MBA, BCPS

Best Practices for Improving Program Performance Through Well-Managed Specialty Pharmacy / Manufacturer Relationships

Authors: Kevin Cast; Kristy Frizzo

AI Chatbot Provides Efficiency and Convenience

Author: Robin M. Coulter, PharmD, MBA, BCPS

Harnessing the Electronic Health Record to Improve Workflow & Reporting in a Hepatitis C Clinic

Authors: Cori L Edmonds, PharmD, BCPS, CSP; Kristen Whelchel, PharmD, CSP

Implementation of an electronic multistep order transmittal process for proactive oral oncolytic prior authorization in an oncology clinic

Authors: B. Kyle Hansen, PharmD, MS, BCPS, CSP; Hannah Lifsey, PharmD, MS; Jennifer Young, PharmD, BCPS, CSP

Specialty Pharmacy Continuity Optimization

Authors: Ryan C Isacsson, PharmD, MBA; Mark D’Ambrosi, RPh, CSP; Aislinn Devoe RN, MSN, CMSRN, CV-BC; Natalie Amendola, BS, CPhT; Todd Cooperman, PharmD, MBA, PRS, PAHM; Vinay Sawant, RPh, MPH, MBA

Specialty Technician Training Program Development

Authors: Diaramalys Rivera, BA, CPhT; Alijah Kosarko, BA, CPhT; Vanessa Batista, CPhT; Brittany Dasher, BS, CPhT; Sharee Parker, CPhT; Vinay Sawant, RPh, MPH, MBA

Collaborative Cancer Nutrition Referral Program

Authors: Matthew Merola, PharmD; Kimhouy Tong, PharmD, BCPS; Terri Sue Rubino, PharmD, CSP; Vinay Sawant, RPh, MPH, MBA

Appeal Approval Rating of Specialty Pharmacists

Authors: Alexis Mod, PharmD; Emily Acheson, PharmD, CSP; Karen Houser, RPh, CSP; Lisa Kenney, PharmD; Svetlana Lyamkin, PharmD, CSP; Allene Naples, PharmD, MBA, CSP, RYT-200

Understanding 505(b)(2) drug purchasing patterns within a home infusion and specialty pharmacy group purchasing organization: An osteoporosis case study

Authors: Stacey Ness, PharmD, CSP, IgCP, MSCS, AAHIVP; Brandon Wilkins; Jack Donahue

IMPLEMENTING A VACCINE SCREENING PROTOCOL FOR SPECIALTY DISEASE MODIFYING ANTI RHEUMATIC DRUGS (DMARDS) IN AN INTEGRATED OUTPATIENT RHEUMATOLOGY CLINIC

Authors: Laura Petry, PharmD; Marci Saknini, PharmD, CSP; Bridget Lynch, PharmD, MD; Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kristen Whelchel, PharmD, CSP

ParcelShield Planner: Intelligent Order Scheduling

Author: Sebastian Pistritto

Specialty pharmacy call center metric optimization

Authors: Bisni Narayanan, Pharm D, MS; Brittany Dasher, BS, CPhT; Terri Sue Rubino, Pharm D, CSP; Vinay Sawant, RPh, MPH, MBA

Compassionate Care In A Specialty Pharmacy

Authors: Aislinn Devoe RN, MSN, CMSRN, CV-BC; Vivien Bergl LCSW, CEAP; Ryan C. Isacsson, PharmD, MBA; Todd Cooperman PharmD, MBA, PRS, PAHM; Vinay Sawant RPH, MPH, MBA; Michele Riccardi PharmD, BCPS

Specialty Pharmacist Led Nursing Education Series

Authors: Michael Zummo, PharmD, CSP; Bisni Narayanan PharmD MS; Brooke Schrameck MSN, RN; Terri Sue Rubino PharmD, CSP; Vinay Sawant RPH, MPH, MBA; Michele Riccardi PharmD, BCPS

Antipsychotics and GSKIP to against neurotoxicant

Author: Ming-der Shi

Impact of a Pharmacist-Driven Appeals Process in an Inflammatory Bowel Disease Clinic

Authors: Alyssa Stewart, PharmD, BCACP, CSP, CPP; Sydney Wooten, PharmD; Jennifer Young, PharmD, BCPS, CSP; Kathy Bricker, PharmD, BCPS; B. Kyle Hansen, PharmD, BCPS, CSP

Pharmacy liaison-managed care model in diabetes

Authors: Martha Stutsky, PharmD; Kristen Ditch, PharmD; Shreevidya Periyasamy, MSHIA; Lillian Piz, MS; Carolkim Huynh, PharmD; Nicholas Bull, PharmD; Jennifer L. Donovan, PharmD; Gary Kerr, PharmD, MBA; Bill McElnea, MPP

Comparing approaches to drive clinical continuity

Authors: Kimhouy Tong, PharmD, BCPS; Ryan Isaccson, PharmD, MBA; Todd Cooperman, MBA, PRS, PAHM; Vinay Sawant, RPh, MPH, MBA

Patient Satisfaction of Delivery Methods and Eco-Friendly Cold Chain Packaging for Medication Deliveries at One Health System Specialty Pharmacy

Authors: Madelyn Harvey, PharmD, MBA, CTTS; Jessica Stewart, PharmD; Ashley Van Camp, PharmD; Elizabeth Rightnour, PharmD

Communities of Practice for Specialty Pharmacies

Authors: Kuwan Blake, BA, CPhT; Dawn DiPasquale, CPhT, CTDP

Real-World Survival in Edaravone-Treated ALS

Authors: Benjamin Rix Brooks, MD; James D. Berry, MD, MPH; Malgorzata Ciepielewska, MS; Jeffrey Zhang, PhD; Ying Liu, PhD; Gustavo Suarez Zambrano, MD; Melissa Hagan, PhD, MPH

ASSESSING PATIENT-REPORTED OUTCOMES AND SPECIALTY PHARMACIST INTERVENTIONS IN MULTIPLE SCLEROSIS

Authors: E. Danielle Bryan, PharmD; Rebekah Finley, PharmD candidate; Nisha B. Shah, PharmD; Ryan Moore, MS; Megan Peter, PhD; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP

ASSESSING PATIENT-REPORTED OUTCOMES WITHIN AN INFLAMMATORY BOWEL DISEASE CLINIC AT AN INTEGRATED CARE CENTER

Authors: E. Danielle Bryan, PharmD; Brooke Welch, PharmD Candidate; Nisha B. Shah, PharmD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Ryan Moore, MS

ASSESSING PATIENT-REPORTED OUTCOMES AND PHARMACIST INTERVENTIONS IN PATIENTS PRESCRIBED SPECIALTY MEDICATIONS FOR DERMATOLOGY AND ASTHMA, SINUS, AND ALLERGY

Authors: E. Danielle Bryan, PharmD; Rebekah Finley, PharmD candidate; Nisha B. Shah, PharmD; Ryan Moore, MS; Josh DeClercq, MS; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP

Assessing Patient-Reported Outcomes and Pharmacist Interventions in Rheumatology Specialty Disease States within an Integrated Care Center

Authors: E. Danielle Bryan, PharmD; Brooke Welch, PharmD candidate; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Nisha B. Shah, PharmD; Megan Peter, PhD; Ryan Moore, MS; Leena Choi, PhD

Assessing Patient-Reported Outcomes within an Integrated Health System Specialty Pharmacy

Authors: E. Danielle Bryan; Katie Hosteng; Autumn D. Zuckerman; Ryan Moore; Leena Choi

Factors Influencing CDK4/6 Inhibitor Adherence

Authors: Navya Clement, PharmD, BCPS, CSP; Martha Stutsky, PharmD, BCPS; Shreevidya Periyasamy, MS HIA; Kate Smullen, PharmD, MSCS; Andrew Argeros; Diane Wolfe, RPh; Jennifer L. Donovan, PharmD

CF Refill Utilization Trends with CFTR Modulators

Authors: Venise R.N. De Etoulem, PharmD; Bonnie Dugie PharmD, MBA, CSP; Sarah Richards, PharmD, CSP

Clinical Outcomes Evaluation and Reporting

Authors: Kristen Ditch, PharmD, BCCCP; Martha Stutsky, PharmD, BCPS; Carolkim Huynh, PharmD, CSP; Christopher Barr; Shreevidya Periyasamy, MS HIA; Kate Smullen, PharmD, CSP, MSCS; Jennifer L. Donovan, PharmD

Outcomes in patients referred to a pharmacist-managed hepatitis C clinic

Authors: Emma Sapp, PharmD, BCACP; Alicia Brunemann, PharmD Candidate 2023; Elizabeth Schlosser, PharmD, BCACP, BCPS; Suzanne Francis, PharmD, BCACP, CDCES

MR Fast: Assessing the impact of health system specialty pharmacy (HSSP) services on helping patients achieve Migraine Relief Fast

Authors: Amanda Hickman, PharmD, MPH, MSCS; Brandon Hardin, PharmD, MBA, CSP; Mona Modi, PharmD Candidate

PERSISTENCE OF VESICULAR MONOAMINE TRANSPORT 2 INHIBITOR THERAPY FOR TOURETTE SYNDROME AND CHRONIC TIC DISORDERS

Authors: Michael Ong, PharmD; Josh DeClercq, MS; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Nisha B. Shah, PharmD; Kayla Johnson, PharmD, BCPS, BCPP; David Isaacs, MD, MPH

Pharmacist Impact on Coverage Outcomes in Oncology

Authors: Young Kim, PharmD, BCMTMS; Martha Stutsky, PharmD, BCPS; Kate Smullen, PharmD, MSCS; Jennifer L. Donovan, PharmD

Impact of an Embedded Rheumatology Pharmacist

Authors: Sefa Kploanyi, PharmD, BCPS; Kate Smullen, PharmD, MSCS, CSP; Martha Stutsky, PharmD, BCPS; Jennifer L. Donovan, PharmD

MANAGEMENT OF PRESCRIPTION CANNABIDIOL ADVERSE EFFECTS AND DRUG-DRUG INTERACTIONS

Authors: Holly Dial, PharmD Candidate; Kayla Johnson, PharmD, BCPS, BCPP; Wendi Owens, CPhT; Sabrina Livezey, PharmD, CSP; Josh DeClercq, MS; Nisha B. Shah, PharmD; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP

RETROSPECTIVE ANALYSIS OF ADVERSE EVENTS AND MEDICATIONS OUTCOMES IN PATIENTS INITIATING ENCORAFENIB AND BINIMETINIB COMBINATION THERAPY

Authors: Brooke D. Looney, PharmD; Stephanie G. White, PharmD; Josh DeClercq, MS; Leena Choi, PhD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Nisha B. Shah, PharmD

Cost impact analysis of clinical interventions collected via specialty pharmacy reporting tool

Authors: Audrey Yeiter, PharmD; Jessica Vinckier, PharmD, CSP; Lauren Lawler, PharmD, AAHIVP, CSP; Kelly Mathews, PharmD, CSP

Development and Implementation of Clinical Dashboards for Clinical Outcomes¬ Measures Reporting Within Health System Specialty Pharmacy Services

Authors: Jessica Mourani, PharmD; Frank Jamison, PharmD; Brandon Hardin, PharmD, MBA, CSP; Amber Skrtic, PharmD, CSP, AAHIVP; Brandon Newman, PharmD, MMHC, CSP; Neda Hanson, PharmD, MPH, CSP; Hector Mayol

Health System Specialty Pharmacy Integration Impact on Fill Time

Authors: Brian M. O’Keefe, PharmD, Jessica Mourani, PharmD

Pharmacist Impact in a Multiple Sclerosis Clinic

Authors: Mekala Paparian, PharmD, MSCS, CSP; Martha Stutsky, PharmD, BCPS; Kate Smullen, PharmD, MSCS, CSP

Hepatitis C Linkage to Care Initiative

Authors: Sandra Poon, PharmD, AAHIVP; Jessica Mourani, PharmD; Jennifer Savory, PharmD, AAHIVP, CSP; Noah Schumacher, PharmD Candidate

Oral oncolytics: adherence, cost and utilization

Authors: Staskon, F., PhD; Kirkham, H., MPH, PhD; Witt, E.A. PhD; Havern, L., PharmD

Integrated Specialty Model Lowers Pharmacy Expense

Authors: Martha Stutsky, PharmD; Dale Fasching, PharmD, MBA; Carolkim Huynh, PharmD; Jennifer L. Donovan, PharmD; Brian S. Smith, PharmD

PERSISTENCE TO HIV PRE-EXPOSURE PROPHYLAXIS FILLED THROUGH AN INTEGRATED HEALTH SYSTEM SPECIALTY PHARMACY COMPARED WITH EXTERNAL PHARMACIES

Authors: Kristen Whelchel, PharmD, CSP; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Josh DeClercq, MS; Leena Choi, PHD; Sean G. Kelly, MD

POLY (ADP-RIBOSE) POLYMERASE INHIBITOR (PARPI) THERAPY: RETROSPECTIVE ANALYSIS OF ADVERSE EVENTS AND TREATMENT MODIFICATIONS DURING THE FIRST 90 DAYS OF THERAPY

Authors: Stephanie G. White, PharmD; Nisha B. Shah, PharmD; Ryan Moore, MS; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Leena Choi, PhD; Matthew J. Brown, MS; Shivani Vora, PharmD; Paul Hueseman, PharmD, MS; Brooke D. Looney, PharmD, CSP

RAPID-3 Metrics for Rheumatoid Arthritis Patients in Specialty Therapy Management

Authors: Alicia Zagel, PhD, MPH; Ann Harty, PharmD, AAHIVP; Eric Betzold, MS; Dana Simonson, PharmD, BCPS; Susan Chhen, PharmD; Tori Grier, PharmD; Ann McNamara, PharmD

DELAY IN INSURANCE APPROVAL OF BIOLOGIC THERAPY DOSE ESCALATION IS ASSOCIATED WITH INCREASED DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Authors: Nisha B. Shah, PharmD; Josh DeClercq, MS; Laura Cherry, PharmD; Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP; Praveen Vimathalas; Leena Choi, PhD; Charles Donoho, BSPharm; Baldeep S. Pabla, MD, MSCI; Elizabeth A. Scoville, MD, MSCI; Robin L. Dalal, MD; Dawn B. Beaulieu, MD; David A. Schwartz, MD; Sara N. Horst, MD, MPH